These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 692285)

  • 21. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in D2 dopamine receptors in the substantia nigra after chronic (-)-sulpiride treatment.
    Stefanini E; Frau M; Gessa GL
    Brain Res; 1991 Aug; 555(2):340-2. PubMed ID: 1834311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra.
    Freed WJ; Ko GN; Niehoff DL; Kuhar MJ; Hoffer BJ; Olson L; Cannon-Spoor HE; Morihisa JM; Wyatt RJ
    Science; 1983 Nov; 222(4626):937-9. PubMed ID: 6635666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
    Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute changes in the state of dopamine receptors; in vitro monitoring with 3H-dopamine.
    Bacopoulos NG
    Life Sci; 1981 Dec; 29(23):2407-14. PubMed ID: 6172691
    [No Abstract]   [Full Text] [Related]  

  • 30. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
    Creese I; Padgett L; Fazzini E; Lopez F
    Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hallucinogen binding to dopamine/neuroleptic receptors.
    Whitaker PM; Seeman P
    J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
    [No Abstract]   [Full Text] [Related]  

  • 33. [3H] spiroperidol binding to brain neurotransmitter receptors.
    Withy RM; Mayer RJ; Strange PG
    FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
    Filloux FM; Wamsley JK; Dawson TM
    Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-affinity 3H-dopamine receptors (D3 sites) in human and rat brain.
    List S; Titeler M; Seeman P
    Biochem Pharmacol; 1980 Jun; 29(11):1621-2. PubMed ID: 7396995
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine (3,4-dihydroxyphenethylamine) receptor binding in subcellular fractions from bovine caudate [proceedings].
    Withy RM; Mayer RJ; Strange PG
    Biochem Soc Trans; 1979 Apr; 7(2):414-6. PubMed ID: 428670
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudo non-competitive agonist interactions with dopamine receptors.
    Sibley DR; Creese I
    Eur J Pharmacol; 1980 Jul; 65(1):131-3. PubMed ID: 7398773
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible relationship between glial cells, dopamine and the effects of antipsychotic drugs.
    Henn FA; Anderson DJ; Sellström A
    Nature; 1977 Apr; 266(5603):637-8. PubMed ID: 859629
    [No Abstract]   [Full Text] [Related]  

  • 40. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.